Carisma Therapeutics, Inc. (CARM)

Carisma Therapeutics Revenue

Carisma Therapeutics had revenue of $15.07M in the twelve months ending March 31, 2024, with 22.99% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $3.40M with 4.75% year-over-year growth. In the year 2023, Carisma Therapeutics had annual revenue of $14.92M with 51.71% growth.

• Revenue (ttm): $15.07M
• Revenue Growth: +22.99%
• P/S Ratio: 3.97
• Revenue / Employee: $140,869
• Employees: 107
• Market Cap: 59.82M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	14.92M	5.09M	51.71%
Dec 31, 2022	9.83M	-16.71M	-62.95%
Dec 31, 2021	26.54M	15.31M	136.24%
Dec 31, 2020	11.24M	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	425.00K	-29.56M	-98.58%
Dec 31, 2016	29.98M	28.99M	2,928.38%
Dec 31, 2015	990.00K	-1.25M	-55.86%
Dec 31, 2014	2.24M	909.00K	68.14%
Dec 31, 2013	1.33M	-	-
Dec 31, 2012	0	-	-
Dec 31, 2011	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.